Old Web
English
Sign In
Acemap
>
authorDetail
>
Gus Alva
Gus Alva
Psychiatry
Psychology
Tolerability
Clinical Global Impression
Iloperidone
5
Papers
67
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (5)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Switching to iloperidone: An omnibus of clinically relevant observations from a 12-week, open-label, randomized clinical trial in 500 persons with schizophrenia.
2015
Clinical Schizophrenia & Related Psychoses
Leslie Citrome
Peter J. Weiden
Gus Alva
Ira D. Glick
Richard Jackson
Greg Mattingly
Farid Kianifard
Xiangyi Meng
Adam Winseck
Show All
Source
Cite
Save
Citations (6)
A trial evaluating gradual- or immediate-switch strategies from risperidone, olanzapine, or aripiprazole to iloperidone in patients with schizophrenia
2014
Schizophrenia Research
Peter J. Weiden
Leslie Citrome
Gus Alva
Matthew Brams
Ira D. Glick
Richard Jackson
Greg Mattingly
Farid Kianifard
Xiangyi Meng
Linda Pestreich
Marla Hochfeld
Adam Winseck
Show All
Source
Cite
Save
Citations (15)
Hierarchical Bayesian cognitive processing models to analyze clinical trial data
2013
Alzheimers & Dementia
William R. Shankle
Junko Hara
Tushar Mangrola
Suzanne Hendrix
Gus Alva
Michael D. Lee
Show All
Source
Cite
Save
Citations (4)
Bayesian cognitive models increase sensitivity for detecting treatment effect: Analysis of Flurizan phase III trial data
2010
Alzheimers & Dementia
William R. Shankle
Gus Alva
Michael D. Lee
Show All
Source
Cite
Save
Citations (0)
A 25-week, open-label trial investigating rivastigmine transdermal patches with concomitant memantine in mild-to-moderate Alzheimer’s disease: a post hoc analysis
2010
Current Medical Research and Opinion
Martin R. Farlow
Gus Alva
Xiangyi Meng
Jason T. Olin
Show All
Source
Cite
Save
Citations (42)
1